Missing/wrong data?
Log in to edit
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment
scientific article published on 21 May 2020
Author/s
author: Lucia Nogova, Matthias Scheffler, Martin L Sos, Thorsten Persigehl, Rieke N Fischer, Masyar Gardizi, Christian Mattonet, Britta Kaminsky, Sabine Merkelbach-Bruse
Work details
Publication date
May 21, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.